

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.53634674 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.53634674 |
| 3 | regulation of cilium movement (GO:0003352) | 7.48338475 |
| 4 | left/right pattern formation (GO:0060972) | 7.47531591 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.20804780 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.20804780 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.80074046 |
| 8 | ventricular system development (GO:0021591) | 6.70447664 |
| 9 | left/right axis specification (GO:0070986) | 6.29721295 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.23463125 |
| 11 | tryptophan catabolic process (GO:0006569) | 6.14728978 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 6.14728978 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 6.14728978 |
| 14 | androgen biosynthetic process (GO:0006702) | 6.12254973 |
| 15 | kynurenine metabolic process (GO:0070189) | 5.99328600 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.91578964 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.78604523 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.71269538 |
| 19 | intraciliary transport (GO:0042073) | 5.70560087 |
| 20 | urea metabolic process (GO:0019627) | 5.62329278 |
| 21 | urea cycle (GO:0000050) | 5.62329278 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 5.62039761 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.50645280 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 5.50485041 |
| 25 | microtubule bundle formation (GO:0001578) | 5.46299287 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 5.43385495 |
| 27 | cysteine metabolic process (GO:0006534) | 5.39175729 |
| 28 | cilium organization (GO:0044782) | 5.39125425 |
| 29 | primary alcohol catabolic process (GO:0034310) | 5.38351610 |
| 30 | complement activation, alternative pathway (GO:0006957) | 5.29830965 |
| 31 | regulation of fibrinolysis (GO:0051917) | 5.29760385 |
| 32 | protein carboxylation (GO:0018214) | 5.27104642 |
| 33 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.27104642 |
| 34 | regulation of protein activation cascade (GO:2000257) | 5.21234909 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 5.17594464 |
| 36 | cilium assembly (GO:0042384) | 5.10370085 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 5.08367794 |
| 38 | bile acid metabolic process (GO:0008206) | 5.06761887 |
| 39 | vitamin transmembrane transport (GO:0035461) | 4.96865167 |
| 40 | aromatic amino acid family metabolic process (GO:0009072) | 4.94239945 |
| 41 | homocysteine metabolic process (GO:0050667) | 4.88350716 |
| 42 | regulation of complement activation (GO:0030449) | 4.87894712 |
| 43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.87227491 |
| 44 | regulation of cholesterol esterification (GO:0010872) | 4.80833466 |
| 45 | reverse cholesterol transport (GO:0043691) | 4.79515627 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.78394231 |
| 47 | regulation of triglyceride catabolic process (GO:0010896) | 4.78246083 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.69693251 |
| 49 | protein-lipid complex remodeling (GO:0034368) | 4.69693251 |
| 50 | macromolecular complex remodeling (GO:0034367) | 4.69693251 |
| 51 | amino-acid betaine metabolic process (GO:0006577) | 4.63598555 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 4.63542886 |
| 53 | progesterone metabolic process (GO:0042448) | 4.60277607 |
| 54 | lysine metabolic process (GO:0006553) | 4.59798547 |
| 55 | lysine catabolic process (GO:0006554) | 4.59798547 |
| 56 | triglyceride homeostasis (GO:0070328) | 4.57120755 |
| 57 | acylglycerol homeostasis (GO:0055090) | 4.57120755 |
| 58 | negative regulation of sterol transport (GO:0032372) | 4.50262453 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 4.50262453 |
| 60 | phospholipid efflux (GO:0033700) | 4.50235207 |
| 61 | ethanol metabolic process (GO:0006067) | 4.47958580 |
| 62 | cilium morphogenesis (GO:0060271) | 4.41593781 |
| 63 | cellular glucuronidation (GO:0052695) | 4.41052518 |
| 64 | bile acid and bile salt transport (GO:0015721) | 4.39172952 |
| 65 | ethanol oxidation (GO:0006069) | 4.37723097 |
| 66 | plasma lipoprotein particle clearance (GO:0034381) | 4.36945877 |
| 67 | glycine metabolic process (GO:0006544) | 4.36779443 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 4.36026503 |
| 69 | indolalkylamine metabolic process (GO:0006586) | 4.35318965 |
| 70 | coenzyme catabolic process (GO:0009109) | 4.34052059 |
| 71 | glucocorticoid biosynthetic process (GO:0006704) | 4.30429457 |
| 72 | imidazole-containing compound metabolic process (GO:0052803) | 4.28736877 |
| 73 | cellular biogenic amine catabolic process (GO:0042402) | 4.28644678 |
| 74 | amine catabolic process (GO:0009310) | 4.28644678 |
| 75 | protein localization to cilium (GO:0061512) | 4.28508666 |
| 76 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.28165857 |
| 77 | cellular amino acid catabolic process (GO:0009063) | 4.27740447 |
| 78 | regulation of microtubule-based movement (GO:0060632) | 4.23523890 |
| 79 | benzene-containing compound metabolic process (GO:0042537) | 4.21654869 |
| 80 | cellular component assembly involved in morphogenesis (GO:0010927) | 4.20521489 |
| 81 | glutamate metabolic process (GO:0006536) | 4.20084445 |
| 82 | serine family amino acid metabolic process (GO:0009069) | 4.16844668 |
| 83 | cholesterol efflux (GO:0033344) | 4.14847147 |
| 84 | nucleoside diphosphate phosphorylation (GO:0006165) | 4.13619617 |
| 85 | lung epithelium development (GO:0060428) | 4.08825207 |
| 86 | microtubule-based movement (GO:0007018) | 4.08551861 |
| 87 | cellular modified amino acid catabolic process (GO:0042219) | 4.04132866 |
| 88 | negative regulation of T cell differentiation in thymus (GO:0033085) | 4.04029899 |
| 89 | drug catabolic process (GO:0042737) | 4.03083404 |
| 90 | aldehyde catabolic process (GO:0046185) | 4.02993851 |
| 91 | arginine metabolic process (GO:0006525) | 3.97245332 |
| 92 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.96667398 |
| 93 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.96438194 |
| 94 | low-density lipoprotein particle remodeling (GO:0034374) | 3.96035611 |
| 95 | serine family amino acid biosynthetic process (GO:0009070) | 3.95475844 |
| 96 | glucuronate metabolic process (GO:0019585) | 3.94991064 |
| 97 | uronic acid metabolic process (GO:0006063) | 3.94991064 |
| 98 | plasma lipoprotein particle assembly (GO:0034377) | 3.94164848 |
| 99 | fibrinolysis (GO:0042730) | 3.93616647 |
| 100 | estrogen biosynthetic process (GO:0006703) | 3.93390924 |
| 101 | androgen metabolic process (GO:0008209) | 3.83180533 |
| 102 | negative regulation of lipase activity (GO:0060192) | 3.80660850 |
| 103 | ketone body metabolic process (GO:1902224) | 3.77362126 |
| 104 | carboxylic acid catabolic process (GO:0046395) | 3.76038633 |
| 105 | organic acid catabolic process (GO:0016054) | 3.76038633 |
| 106 | cofactor catabolic process (GO:0051187) | 3.75534666 |
| 107 | blood coagulation, intrinsic pathway (GO:0007597) | 3.75191175 |
| 108 | short-chain fatty acid metabolic process (GO:0046459) | 3.74043183 |
| 109 | phospholipid homeostasis (GO:0055091) | 3.73920692 |
| 110 | positive regulation of lipid catabolic process (GO:0050996) | 3.72967199 |
| 111 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.72286128 |
| 112 | sperm capacitation (GO:0048240) | 3.72276282 |
| 113 | acetyl-CoA metabolic process (GO:0006084) | 3.71957071 |
| 114 | regulation of bile acid biosynthetic process (GO:0070857) | 3.71929097 |
| 115 | response to nitrosative stress (GO:0051409) | 3.71415002 |
| 116 | cholesterol homeostasis (GO:0042632) | 3.71206066 |
| 117 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.71032365 |
| 118 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.71032365 |
| 119 | melanin biosynthetic process (GO:0042438) | 3.69756683 |
| 120 | complement activation, classical pathway (GO:0006958) | 3.68608858 |
| 121 | hormone biosynthetic process (GO:0042446) | 3.68322471 |
| 122 | complement activation (GO:0006956) | 3.67095547 |
| 123 | cell projection assembly (GO:0030031) | 3.66618392 |
| 124 | retinal rod cell development (GO:0046548) | 3.65767435 |
| 125 | sterol homeostasis (GO:0055092) | 3.65148484 |
| 126 | one-carbon compound transport (GO:0019755) | 3.64305009 |
| 127 | protein activation cascade (GO:0072376) | 3.64253853 |
| 128 | diterpenoid biosynthetic process (GO:0016102) | 3.64192215 |
| 129 | cytolysis (GO:0019835) | 3.60595739 |
| 130 | regulation of cholesterol homeostasis (GO:2000188) | 3.58377028 |
| 131 | flavonoid metabolic process (GO:0009812) | 3.58290335 |
| 132 | cellular response to antibiotic (GO:0071236) | 3.56821674 |
| 133 | plasma lipoprotein particle organization (GO:0071827) | 3.56535203 |
| 134 | response to xenobiotic stimulus (GO:0009410) | 3.55914227 |
| 135 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.54467909 |
| 136 | centriole assembly (GO:0098534) | 3.53898663 |
| 137 | * glutathione derivative biosynthetic process (GO:1901687) | 3.46842380 |
| 138 | * glutathione derivative metabolic process (GO:1901685) | 3.46842380 |
| 139 | negative regulation of humoral immune response (GO:0002921) | 3.42693722 |
| 140 | terpenoid biosynthetic process (GO:0016114) | 3.41403174 |
| 141 | C21-steroid hormone metabolic process (GO:0008207) | 3.37302930 |
| 142 | cytoplasmic microtubule organization (GO:0031122) | 3.33368454 |
| 143 | glomerular epithelial cell development (GO:0072310) | 3.32248570 |
| 144 | regulation of interleukin-5 production (GO:0032674) | 3.31697267 |
| 145 | melanin metabolic process (GO:0006582) | 3.31019766 |
| 146 | negative regulation of B cell mediated immunity (GO:0002713) | 3.26792606 |
| 147 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.26792606 |
| 148 | tolerance induction (GO:0002507) | 3.25117932 |
| 149 | C21-steroid hormone biosynthetic process (GO:0006700) | 3.24360883 |
| 150 | glucocorticoid metabolic process (GO:0008211) | 3.18548464 |
| 151 | amyloid precursor protein catabolic process (GO:0042987) | 3.15479369 |
| 152 | secondary metabolite biosynthetic process (GO:0044550) | 3.14602103 |
| 153 | regulation of autophagic vacuole assembly (GO:2000785) | 3.14384145 |
| 154 | determination of left/right symmetry (GO:0007368) | 3.14012994 |
| 155 | response to follicle-stimulating hormone (GO:0032354) | 3.06532999 |
| 156 | multicellular organismal water homeostasis (GO:0050891) | 3.06228363 |
| 157 | determination of bilateral symmetry (GO:0009855) | 3.03825623 |
| 158 | establishment of apical/basal cell polarity (GO:0035089) | 3.02963647 |
| 159 | ketone biosynthetic process (GO:0042181) | 3.00107214 |
| 160 | lateral ventricle development (GO:0021670) | 3.00085580 |
| 161 | primary alcohol metabolic process (GO:0034308) | 2.98541159 |
| 162 | specification of symmetry (GO:0009799) | 2.98501148 |
| 163 | photoreceptor cell maintenance (GO:0045494) | 2.94093199 |
| 164 | exogenous drug catabolic process (GO:0042738) | 2.84863411 |
| 165 | Leydig cell differentiation (GO:0033327) | 2.83906723 |
| 166 | sperm motility (GO:0030317) | 2.83777381 |
| 167 | multicellular organismal aging (GO:0010259) | 2.83667229 |
| 168 | regulation of vacuole organization (GO:0044088) | 2.81840834 |
| 169 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.80741830 |
| 170 | retinol metabolic process (GO:0042572) | 2.79335702 |
| 171 | cornea development in camera-type eye (GO:0061303) | 2.72570351 |
| 172 | cellular response to gonadotropin stimulus (GO:0071371) | 2.71397571 |
| 173 | regulation of interleukin-13 production (GO:0032656) | 2.66330596 |
| 174 | response to leptin (GO:0044321) | 2.64392104 |
| 175 | retinoic acid metabolic process (GO:0042573) | 2.61208837 |
| 176 | establishment of planar polarity (GO:0001736) | 2.60632193 |
| 177 | establishment of tissue polarity (GO:0007164) | 2.60632193 |
| 178 | water homeostasis (GO:0030104) | 2.60596825 |
| 179 | regulation of germinal center formation (GO:0002634) | 2.59862653 |
| 180 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.59072501 |
| 181 | retinal cone cell development (GO:0046549) | 2.56216718 |
| 182 | apical protein localization (GO:0045176) | 2.52520717 |
| 183 | GTP biosynthetic process (GO:0006183) | 2.51228324 |
| 184 | carnitine metabolic process (GO:0009437) | 2.50603535 |
| 185 | smoothened signaling pathway (GO:0007224) | 2.49887782 |
| 186 | establishment of monopolar cell polarity (GO:0061162) | 2.48723845 |
| 187 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.48723845 |
| 188 | cellular response to toxic substance (GO:0097237) | 2.47497108 |
| 189 | regulation of gonadotropin secretion (GO:0032276) | 2.39227370 |
| 190 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.38796013 |
| 191 | axonemal dynein complex assembly (GO:0070286) | 18.9853152 |
| 192 | cilium or flagellum-dependent cell motility (GO:0001539) | 15.3573149 |
| 193 | cilium movement (GO:0003341) | 15.0190904 |
| 194 | epithelial cilium movement (GO:0003351) | 13.8244528 |
| 195 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 13.2407431 |
| 196 | motile cilium assembly (GO:0044458) | 13.0962404 |
| 197 | axoneme assembly (GO:0035082) | 10.2297487 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.31901562 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.13870686 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.96172380 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.46619427 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.25435804 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 5.09334124 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.03333876 |
| 8 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.00088573 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.03200937 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.99305264 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.95945721 |
| 12 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.15309548 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08198021 |
| 14 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.06284737 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.04558246 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.00746687 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8052825 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98337264 |
| 19 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.97548577 |
| 20 | VDR_22108803_ChIP-Seq_LS180_Human | 1.94952161 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.93334906 |
| 22 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.87389863 |
| 23 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.81664573 |
| 24 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.68735702 |
| 25 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.62567351 |
| 26 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60323160 |
| 27 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.58246999 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56816351 |
| 29 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.55883501 |
| 30 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.52760549 |
| 31 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.49390338 |
| 32 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.48629213 |
| 33 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.46783041 |
| 34 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42890422 |
| 35 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39940473 |
| 36 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.36876205 |
| 37 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.32527338 |
| 38 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.30740405 |
| 39 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.27962444 |
| 40 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.27550247 |
| 41 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.26644677 |
| 42 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.25658595 |
| 43 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24516037 |
| 44 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.21900368 |
| 45 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.21479943 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20763692 |
| 47 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.18903131 |
| 48 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.18534659 |
| 49 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.17262279 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17176619 |
| 51 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.17023772 |
| 52 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.16991529 |
| 53 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.16727234 |
| 54 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15016032 |
| 55 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.13059320 |
| 56 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.13059320 |
| 57 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.12838327 |
| 58 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.09178143 |
| 59 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.08738559 |
| 60 | TBL1_22424771_ChIP-Seq_293T_Human | 1.08504950 |
| 61 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.06795491 |
| 62 | NFYA_21822215_ChIP-Seq_K562_Human | 1.06659087 |
| 63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06558518 |
| 64 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.06113887 |
| 65 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.03865970 |
| 66 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03762512 |
| 67 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.03652384 |
| 68 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.03300784 |
| 69 | NFYB_21822215_ChIP-Seq_K562_Human | 1.01493644 |
| 70 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01165718 |
| 71 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99345114 |
| 72 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.99096764 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.98521189 |
| 74 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98454792 |
| 75 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98390963 |
| 76 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.96670675 |
| 77 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.95826771 |
| 78 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.95545008 |
| 79 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.95295160 |
| 80 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94215362 |
| 81 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.94147832 |
| 82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93549657 |
| 83 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93064194 |
| 84 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.92329462 |
| 85 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91648178 |
| 86 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.91054700 |
| 87 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.89919642 |
| 88 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.89910555 |
| 89 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.89203159 |
| 90 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.89203159 |
| 91 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88479141 |
| 92 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88479141 |
| 93 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88114993 |
| 94 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87379916 |
| 95 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.85718507 |
| 96 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.83883181 |
| 97 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83488006 |
| 98 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82517344 |
| 99 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.81197882 |
| 100 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81182591 |
| 101 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79555640 |
| 102 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.79045237 |
| 103 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77757282 |
| 104 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77635770 |
| 105 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75932728 |
| 106 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.75351799 |
| 107 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.75176027 |
| 108 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.74634522 |
| 109 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71768632 |
| 110 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.70566563 |
| 111 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70022743 |
| 112 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.68480610 |
| 113 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.68480610 |
| 114 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.67616740 |
| 115 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62234924 |
| 116 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62135800 |
| 117 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61972013 |
| 118 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60842010 |
| 119 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.59116109 |
| 120 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58458034 |
| 121 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.57619113 |
| 122 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.56820870 |
| 123 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.56066527 |
| 124 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.53305046 |
| 125 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.53157027 |
| 126 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.52864692 |
| 127 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52408255 |
| 128 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51640900 |
| 129 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.51303614 |
| 130 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51027535 |
| 131 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50771255 |
| 132 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.50510898 |
| 133 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.50239738 |
| 134 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.50072888 |
| 135 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.49305502 |
| 136 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.48455909 |
| 137 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48366390 |
| 138 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.47822858 |
| 139 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47010491 |
| 140 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.46056794 |
| 141 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45069351 |
| 142 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44745869 |
| 143 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43926528 |
| 144 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.43773528 |
| 145 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.43055552 |
| 146 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.42714314 |
| 147 | GATA1_19941826_ChIP-Seq_K562_Human | 0.42670963 |
| 148 | GATA2_19941826_ChIP-Seq_K562_Human | 0.40852517 |
| 149 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39522850 |
| 150 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.39289256 |
| 151 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.39013940 |
| 152 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.38432143 |
| 153 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38302047 |
| 154 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.37877441 |
| 155 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.37605475 |
| 156 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.37564113 |
| 157 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.37037044 |
| 158 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36235151 |
| 159 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.36032022 |
| 160 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.35885133 |
| 161 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.35858685 |
| 162 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.34990895 |
| 163 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34879375 |
| 164 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.34549752 |
| 165 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34420329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.34777515 |
| 2 | MP0005360_urolithiasis | 7.42592396 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.41275332 |
| 4 | MP0005365_abnormal_bile_salt | 6.18527116 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.32330458 |
| 6 | MP0002653_abnormal_ependyma_morphology | 4.83985848 |
| 7 | MP0001984_abnormal_olfaction | 4.41855142 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 4.24514965 |
| 9 | MP0003252_abnormal_bile_duct | 3.88974150 |
| 10 | MP0000566_synostosis | 3.72957156 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.58658206 |
| 12 | MP0000372_irregular_coat_pigmentation | 3.53432358 |
| 13 | MP0003136_yellow_coat_color | 3.44692478 |
| 14 | MP0009840_abnormal_foam_cell | 3.18314886 |
| 15 | MP0005083_abnormal_biliary_tract | 3.12325454 |
| 16 | MP0002909_abnormal_adrenal_gland | 3.10797142 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.79147434 |
| 18 | MP0003195_calcinosis | 2.76925605 |
| 19 | MP0005332_abnormal_amino_acid | 2.75933060 |
| 20 | MP0004133_heterotaxia | 2.71757124 |
| 21 | MP0002160_abnormal_reproductive_system | 2.70191069 |
| 22 | MP0001666_abnormal_nutrient_absorption | 2.57201314 |
| 23 | MP0004043_abnormal_pH_regulation | 2.33997585 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.27189220 |
| 25 | MP0008995_early_reproductive_senescence | 2.26550978 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 2.21968863 |
| 27 | MP0000383_abnormal_hair_follicle | 2.15938877 |
| 28 | MP0000609_abnormal_liver_physiology | 2.14531589 |
| 29 | MP0002118_abnormal_lipid_homeostasis | 2.10748530 |
| 30 | MP0005623_abnormal_meninges_morphology | 2.10456965 |
| 31 | MP0002277_abnormal_respiratory_mucosa | 2.03538896 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 2.03321861 |
| 33 | MP0008789_abnormal_olfactory_epithelium | 1.92168302 |
| 34 | MP0003868_abnormal_feces_composition | 1.89210785 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.83130221 |
| 36 | MP0002282_abnormal_trachea_morphology | 1.82223180 |
| 37 | MP0005377_hearing/vestibular/ear_phenot | 1.78770746 |
| 38 | MP0003878_abnormal_ear_physiology | 1.78770746 |
| 39 | MP0010678_abnormal_skin_adnexa | 1.69747228 |
| 40 | MP0001764_abnormal_homeostasis | 1.68362161 |
| 41 | MP0005389_reproductive_system_phenotype | 1.58877339 |
| 42 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56470162 |
| 43 | MP0009697_abnormal_copulation | 1.56358210 |
| 44 | MP0009379_abnormal_foot_pigmentation | 1.55040836 |
| 45 | MP0001324_abnormal_eye_pigmentation | 1.50653078 |
| 46 | MP0001765_abnormal_ion_homeostasis | 1.41506645 |
| 47 | MP0005451_abnormal_body_composition | 1.40924078 |
| 48 | MP0003186_abnormal_redox_activity | 1.40392903 |
| 49 | MP0003011_delayed_dark_adaptation | 1.40221674 |
| 50 | MP0002938_white_spotting | 1.39401267 |
| 51 | MP0005171_absent_coat_pigmentation | 1.38034387 |
| 52 | MP0010030_abnormal_orbit_morphology | 1.36047179 |
| 53 | MP0009643_abnormal_urine_homeostasis | 1.26642964 |
| 54 | MP0003656_abnormal_erythrocyte_physiolo | 1.21900949 |
| 55 | MP0000013_abnormal_adipose_tissue | 1.21238134 |
| 56 | MP0005253_abnormal_eye_physiology | 1.20409094 |
| 57 | MP0000598_abnormal_liver_morphology | 1.16178612 |
| 58 | MP0005647_abnormal_sex_gland | 1.13308314 |
| 59 | MP0003123_paternal_imprinting | 1.12361677 |
| 60 | MP0003705_abnormal_hypodermis_morpholog | 1.11007803 |
| 61 | MP0001485_abnormal_pinna_reflex | 1.10707252 |
| 62 | MP0002638_abnormal_pupillary_reflex | 1.08352087 |
| 63 | MP0003283_abnormal_digestive_organ | 1.07993018 |
| 64 | MP0009764_decreased_sensitivity_to | 1.07386428 |
| 65 | MP0002254_reproductive_system_inflammat | 1.05747685 |
| 66 | MP0005409_darkened_coat_color | 1.01940772 |
| 67 | MP0000604_amyloidosis | 0.99670537 |
| 68 | MP0010368_abnormal_lymphatic_system | 0.97858618 |
| 69 | * MP0009763_increased_sensitivity_to | 0.95718879 |
| 70 | MP0005551_abnormal_eye_electrophysiolog | 0.94094918 |
| 71 | MP0005636_abnormal_mineral_homeostasis | 0.92536281 |
| 72 | MP0005499_abnormal_olfactory_system | 0.91716069 |
| 73 | MP0005394_taste/olfaction_phenotype | 0.91716069 |
| 74 | MP0005503_abnormal_tendon_morphology | 0.91393050 |
| 75 | MP0005408_hypopigmentation | 0.88981667 |
| 76 | MP0002233_abnormal_nose_morphology | 0.88941892 |
| 77 | MP0005670_abnormal_white_adipose | 0.87962802 |
| 78 | MP0002098_abnormal_vibrissa_morphology | 0.87411349 |
| 79 | MP0008469_abnormal_protein_level | 0.86972457 |
| 80 | MP0009642_abnormal_blood_homeostasis | 0.85734890 |
| 81 | MP0008004_abnormal_stomach_pH | 0.84289834 |
| 82 | MP0010234_abnormal_vibrissa_follicle | 0.83860924 |
| 83 | MP0001929_abnormal_gametogenesis | 0.83340391 |
| 84 | MP0003698_abnormal_male_reproductive | 0.82357423 |
| 85 | MP0002876_abnormal_thyroid_physiology | 0.81770108 |
| 86 | MP0005376_homeostasis/metabolism_phenot | 0.80741253 |
| 87 | MP0005075_abnormal_melanosome_morpholog | 0.80238249 |
| 88 | MP0006036_abnormal_mitochondrial_physio | 0.80229770 |
| 89 | MP0005084_abnormal_gallbladder_morpholo | 0.79801837 |
| 90 | MP0000647_abnormal_sebaceous_gland | 0.79588696 |
| 91 | MP0002734_abnormal_mechanical_nocicepti | 0.78571071 |
| 92 | MP0002078_abnormal_glucose_homeostasis | 0.77128764 |
| 93 | MP0005220_abnormal_exocrine_pancreas | 0.73140122 |
| 94 | MP0004130_abnormal_muscle_cell | 0.72487121 |
| 95 | MP0002971_abnormal_brown_adipose | 0.71861516 |
| 96 | MP0005187_abnormal_penis_morphology | 0.71821846 |
| 97 | MP0005334_abnormal_fat_pad | 0.71121284 |
| 98 | MP0003690_abnormal_glial_cell | 0.69295954 |
| 99 | MP0003941_abnormal_skin_development | 0.69267569 |
| 100 | MP0001661_extended_life_span | 0.67331563 |
| 101 | MP0002896_abnormal_bone_mineralization | 0.67007911 |
| 102 | MP0005535_abnormal_body_temperature | 0.66597075 |
| 103 | MP0006276_abnormal_autonomic_nervous | 0.65994116 |
| 104 | * MP0009765_abnormal_xenobiotic_induced | 0.65228287 |
| 105 | MP0005266_abnormal_metabolism | 0.65107488 |
| 106 | MP0009053_abnormal_anal_canal | 0.63608957 |
| 107 | MP0005508_abnormal_skeleton_morphology | 0.63113497 |
| 108 | MP0001756_abnormal_urination | 0.63022814 |
| 109 | MP0001502_abnormal_circadian_rhythm | 0.59556524 |
| 110 | MP0000015_abnormal_ear_pigmentation | 0.59086562 |
| 111 | MP0000639_abnormal_adrenal_gland | 0.57798532 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.57411920 |
| 113 | MP0009046_muscle_twitch | 0.57134590 |
| 114 | MP0003329_amyloid_beta_deposits | 0.56999570 |
| 115 | MP0009703_decreased_birth_body | 0.56477111 |
| 116 | MP0005448_abnormal_energy_balance | 0.53562379 |
| 117 | MP0001188_hyperpigmentation | 0.52139784 |
| 118 | MP0006035_abnormal_mitochondrial_morpho | 0.51573819 |
| 119 | MP0000371_diluted_coat_color | 0.51321713 |
| 120 | MP0000026_abnormal_inner_ear | 0.50382079 |
| 121 | MP0005464_abnormal_platelet_physiology | 0.49751079 |
| 122 | MP0005395_other_phenotype | 0.49572762 |
| 123 | MP0003937_abnormal_limbs/digits/tail_de | 0.49466510 |
| 124 | MP0002136_abnormal_kidney_physiology | 0.49010984 |
| 125 | MP0005248_abnormal_Harderian_gland | 0.47570841 |
| 126 | MP0002928_abnormal_bile_duct | 0.47288268 |
| 127 | MP0003724_increased_susceptibility_to | 0.47096606 |
| 128 | MP0002229_neurodegeneration | 0.46649574 |
| 129 | MP0003638_abnormal_response/metabolism_ | 0.45457378 |
| 130 | MP0003718_maternal_effect | 0.45156845 |
| 131 | MP0003453_abnormal_keratinocyte_physiol | 0.44112581 |
| 132 | MP0008874_decreased_physiological_sensi | 0.43476045 |
| 133 | MP0002210_abnormal_sex_determination | 0.42742924 |
| 134 | MP0002822_catalepsy | 0.42664545 |
| 135 | MP0005666_abnormal_adipose_tissue | 0.41726896 |
| 136 | MP0003075_altered_response_to | 0.41665986 |
| 137 | MP0003953_abnormal_hormone_level | 0.41287564 |
| 138 | MP0002837_dystrophic_cardiac_calcinosis | 0.40791283 |
| 139 | MP0008872_abnormal_physiological_respon | 0.40130347 |
| 140 | MP0003436_decreased_susceptibility_to | 0.39021798 |
| 141 | MP0005166_decreased_susceptibility_to | 0.37733876 |
| 142 | MP0004381_abnormal_hair_follicle | 0.37318729 |
| 143 | MP0002796_impaired_skin_barrier | 0.37241901 |
| 144 | MP0009115_abnormal_fat_cell | 0.36977046 |
| 145 | * MP0008873_increased_physiological_sensi | 0.35826096 |
| 146 | MP0002168_other_aberrant_phenotype | 0.35454180 |
| 147 | MP0009672_abnormal_birth_weight | 0.33979185 |
| 148 | MP0000249_abnormal_blood_vessel | 0.32884399 |
| 149 | MP0000579_abnormal_nail_morphology | 0.32540385 |
| 150 | MP0004883_abnormal_blood_vessel | 0.32163682 |
| 151 | MP0000230_abnormal_systemic_arterial | 0.31808258 |
| 152 | MP0002970_abnormal_white_adipose | 0.31362834 |
| 153 | MP0002132_abnormal_respiratory_system | 0.31067221 |
| 154 | MP0006082_CNS_inflammation | 0.30454635 |
| 155 | MP0009384_cardiac_valve_regurgitation | 0.30281186 |
| 156 | MP0001853_heart_inflammation | 0.29948290 |
| 157 | MP0001243_abnormal_dermal_layer | 0.29930125 |
| 158 | MP0001881_abnormal_mammary_gland | 0.28887612 |
| 159 | MP0005164_abnormal_response_to | 0.28765260 |
| 160 | MP0002060_abnormal_skin_morphology | 0.27354415 |
| 161 | MP0001845_abnormal_inflammatory_respons | 0.27255952 |
| 162 | MP0002090_abnormal_vision | 0.26536694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Rhinitis (HP:0012384) | 9.52592995 |
| 2 | Chronic bronchitis (HP:0004469) | 7.45679298 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.39535159 |
| 4 | Deep venous thrombosis (HP:0002625) | 7.38108936 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 7.27093315 |
| 6 | Bronchiectasis (HP:0002110) | 6.80205400 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.70585274 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 6.47961406 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 6.40261766 |
| 10 | Xanthomatosis (HP:0000991) | 6.24450741 |
| 11 | Nasal polyposis (HP:0100582) | 6.06645244 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 5.54723027 |
| 13 | Complement deficiency (HP:0004431) | 5.31342313 |
| 14 | Abnormality of the nasal mucosa (HP:0000433) | 4.98309814 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.77638389 |
| 16 | Joint hemorrhage (HP:0005261) | 4.75681644 |
| 17 | Hyperammonemia (HP:0001987) | 4.62380641 |
| 18 | Epidermoid cyst (HP:0200040) | 4.54968639 |
| 19 | Hyperglycinemia (HP:0002154) | 4.46555500 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.38043986 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 4.33654846 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 4.30581169 |
| 23 | Ketosis (HP:0001946) | 4.26684239 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.25255132 |
| 25 | Infertility (HP:0000789) | 4.23218248 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.20592845 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 4.16195689 |
| 28 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.15991805 |
| 29 | Fat malabsorption (HP:0002630) | 4.14437944 |
| 30 | Hyperglycinuria (HP:0003108) | 4.06465455 |
| 31 | Chronic sinusitis (HP:0011109) | 4.04732371 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 4.01005654 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.01005654 |
| 34 | Bronchitis (HP:0012387) | 3.96198003 |
| 35 | Abnormality of complement system (HP:0005339) | 3.86597493 |
| 36 | Hypoglycemic coma (HP:0001325) | 3.86382540 |
| 37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.84153352 |
| 38 | Male infertility (HP:0003251) | 3.82204186 |
| 39 | Recurrent sinusitis (HP:0011108) | 3.74697301 |
| 40 | Abnormality of the intrinsic pathway (HP:0010989) | 3.73298441 |
| 41 | Conjugated hyperbilirubinemia (HP:0002908) | 3.71998256 |
| 42 | Occipital encephalocele (HP:0002085) | 3.68602415 |
| 43 | Hypercholesterolemia (HP:0003124) | 3.62748580 |
| 44 | Recurrent otitis media (HP:0000403) | 3.55491425 |
| 45 | True hermaphroditism (HP:0010459) | 3.47173493 |
| 46 | Pancreatic fibrosis (HP:0100732) | 3.44531102 |
| 47 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.39659895 |
| 48 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.38854789 |
| 49 | Hyperbilirubinemia (HP:0002904) | 3.33883220 |
| 50 | Steatorrhea (HP:0002570) | 3.16850974 |
| 51 | Molar tooth sign on MRI (HP:0002419) | 3.14690461 |
| 52 | Abnormality of midbrain morphology (HP:0002418) | 3.14690461 |
| 53 | Delayed CNS myelination (HP:0002188) | 3.12459460 |
| 54 | Abnormality of nucleobase metabolism (HP:0010932) | 3.12012956 |
| 55 | Abnormality of serum amino acid levels (HP:0003112) | 3.10682171 |
| 56 | Male pseudohermaphroditism (HP:0000037) | 3.07135748 |
| 57 | Ketoacidosis (HP:0001993) | 3.05085724 |
| 58 | Hepatocellular carcinoma (HP:0001402) | 3.00866207 |
| 59 | Myocardial infarction (HP:0001658) | 2.93006996 |
| 60 | Hypochromic microcytic anemia (HP:0004840) | 2.88475593 |
| 61 | Pancreatic cysts (HP:0001737) | 2.86925868 |
| 62 | Spontaneous abortion (HP:0005268) | 2.86581554 |
| 63 | Nephronophthisis (HP:0000090) | 2.85430744 |
| 64 | Renal salt wasting (HP:0000127) | 2.83014725 |
| 65 | Metabolic acidosis (HP:0001942) | 2.79507790 |
| 66 | Skin nodule (HP:0200036) | 2.78999780 |
| 67 | Abnormality of purine metabolism (HP:0004352) | 2.75942758 |
| 68 | Systemic lupus erythematosus (HP:0002725) | 2.72040361 |
| 69 | Cystic liver disease (HP:0006706) | 2.70728213 |
| 70 | Chronic hepatic failure (HP:0100626) | 2.70688590 |
| 71 | Vascular calcification (HP:0004934) | 2.64587130 |
| 72 | Lethargy (HP:0001254) | 2.63335175 |
| 73 | Dicarboxylic aciduria (HP:0003215) | 2.60605260 |
| 74 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.60605260 |
| 75 | Chronic otitis media (HP:0000389) | 2.57787968 |
| 76 | Gout (HP:0001997) | 2.57190248 |
| 77 | Acanthocytosis (HP:0001927) | 2.54339559 |
| 78 | Spastic diplegia (HP:0001264) | 2.50066552 |
| 79 | Hypoglycemic seizures (HP:0002173) | 2.46726959 |
| 80 | Medial flaring of the eyebrow (HP:0010747) | 2.46419657 |
| 81 | Abnormal gallbladder morphology (HP:0012437) | 2.46364900 |
| 82 | Tubulointerstitial nephritis (HP:0001970) | 2.45775291 |
| 83 | Cerebral edema (HP:0002181) | 2.41584613 |
| 84 | Atelectasis (HP:0100750) | 2.41565832 |
| 85 | Glomerulonephritis (HP:0000099) | 2.41199985 |
| 86 | Mitral stenosis (HP:0001718) | 2.40726454 |
| 87 | Cholelithiasis (HP:0001081) | 2.38880288 |
| 88 | Postaxial foot polydactyly (HP:0001830) | 2.35084912 |
| 89 | Cardiovascular calcification (HP:0011915) | 2.34681873 |
| 90 | Irritability (HP:0000737) | 2.34669609 |
| 91 | Abnormal gallbladder physiology (HP:0012438) | 2.33850686 |
| 92 | Cholecystitis (HP:0001082) | 2.33850686 |
| 93 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.31207651 |
| 94 | Neonatal onset (HP:0003623) | 2.31073495 |
| 95 | Esophageal varix (HP:0002040) | 2.28968172 |
| 96 | Decreased circulating renin level (HP:0003351) | 2.26269530 |
| 97 | Hyperactive renin-angiotensin system (HP:0000841) | 2.25575187 |
| 98 | Amyloidosis (HP:0011034) | 2.25565917 |
| 99 | Malnutrition (HP:0004395) | 2.25077394 |
| 100 | Pancreatitis (HP:0001733) | 2.15173884 |
| 101 | Abnormality of the renal medulla (HP:0100957) | 2.13898339 |
| 102 | Brushfield spots (HP:0001088) | 2.13695609 |
| 103 | Sensorimotor neuropathy (HP:0007141) | 2.12772189 |
| 104 | Enlarged kidneys (HP:0000105) | 2.11267079 |
| 105 | Gingival bleeding (HP:0000225) | 2.11152838 |
| 106 | Menorrhagia (HP:0000132) | 2.10890984 |
| 107 | Vomiting (HP:0002013) | 2.08809345 |
| 108 | Late onset (HP:0003584) | 2.08657516 |
| 109 | Hyperaldosteronism (HP:0000859) | 2.06931325 |
| 110 | Generalized aminoaciduria (HP:0002909) | 2.06412436 |
| 111 | Congenital primary aphakia (HP:0007707) | 2.06150779 |
| 112 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.05124497 |
| 113 | Congenital hepatic fibrosis (HP:0002612) | 2.05042038 |
| 114 | Thrombophlebitis (HP:0004418) | 2.03458047 |
| 115 | Opisthotonus (HP:0002179) | 2.02535182 |
| 116 | Hemorrhage of the eye (HP:0011885) | 2.00794647 |
| 117 | Abnormality of the gallbladder (HP:0005264) | 2.00515799 |
| 118 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 11.8908678 |
| 119 | Abnormal respiratory motile cilium physiology (HP:0012261) | 10.8553113 |
| 120 | Abnormal ciliary motility (HP:0012262) | 10.7250670 |
| 121 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 10.6055236 |
| 122 | Absent/shortened dynein arms (HP:0200106) | 10.6055236 |
| 123 | Abnormal respiratory epithelium morphology (HP:0012253) | 10.6011249 |
| 124 | Abnormal respiratory motile cilium morphology (HP:0005938) | 10.6011249 |
| 125 | Gait imbalance (HP:0002141) | 1.99984731 |
| 126 | Rickets (HP:0002748) | 1.99567942 |
| 127 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.97996889 |
| 128 | Poikilocytosis (HP:0004447) | 1.96843206 |
| 129 | Abnormal cartilage morphology (HP:0002763) | 1.95387769 |
| 130 | Short nail (HP:0001799) | 1.93662065 |
| 131 | Abnormality of proline metabolism (HP:0010907) | 1.93365590 |
| 132 | Hydroxyprolinuria (HP:0003080) | 1.93365590 |
| 133 | Renal cortical cysts (HP:0000803) | 1.92096855 |
| 134 | Alkalosis (HP:0001948) | 1.89478048 |
| 135 | Abnormality of iron homeostasis (HP:0011031) | 1.87557952 |
| 136 | Tubular atrophy (HP:0000092) | 1.86757606 |
| 137 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86000548 |
| 138 | Furrowed tongue (HP:0000221) | 1.85339396 |
| 139 | Anencephaly (HP:0002323) | 1.85018594 |
| 140 | Hypophosphatemic rickets (HP:0004912) | 1.84724783 |
| 141 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83201124 |
| 142 | Elevated hepatic transaminases (HP:0002910) | 1.80902699 |
| 143 | Abnormality of vitamin metabolism (HP:0100508) | 1.79104278 |
| 144 | Tubulointerstitial abnormality (HP:0001969) | 1.78908183 |
| 145 | Nephritis (HP:0000123) | 1.76479359 |
| 146 | Hyperuricemia (HP:0002149) | 1.75782525 |
| 147 | Increased purine levels (HP:0004368) | 1.75782525 |
| 148 | Nephrogenic diabetes insipidus (HP:0009806) | 1.74110064 |
| 149 | Oculomotor apraxia (HP:0000657) | 1.68167107 |
| 150 | Abnormality of permanent molar morphology (HP:0011071) | 1.66743320 |
| 151 | Abnormality of the dental root (HP:0006486) | 1.66743320 |
| 152 | Taurodontia (HP:0000679) | 1.66743320 |
| 153 | Sclerocornea (HP:0000647) | 1.65855417 |
| 154 | Postaxial hand polydactyly (HP:0001162) | 1.60069221 |
| 155 | Genital tract atresia (HP:0001827) | 1.59562569 |
| 156 | Abnormal sex determination (HP:0012244) | 1.59438571 |
| 157 | Sex reversal (HP:0012245) | 1.59438571 |
| 158 | Decreased central vision (HP:0007663) | 1.59398701 |
| 159 | Hypokalemic alkalosis (HP:0001949) | 1.58356804 |
| 160 | Vaginal atresia (HP:0000148) | 1.58260842 |
| 161 | Abnormality of the dental pulp (HP:0006479) | 1.55944668 |
| 162 | Recurrent bronchitis (HP:0002837) | 1.55929614 |
| 163 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.55006424 |
| 164 | Median cleft lip (HP:0000161) | 1.53437435 |
| 165 | Abnormality of molar morphology (HP:0011070) | 1.53024897 |
| 166 | Abnormality of molar (HP:0011077) | 1.53024897 |
| 167 | Tubulointerstitial fibrosis (HP:0005576) | 1.52827522 |
| 168 | Cone-rod dystrophy (HP:0000548) | 1.51334186 |
| 169 | Absent frontal sinuses (HP:0002688) | 1.50912378 |
| 170 | Hypoplasia of the uterus (HP:0000013) | 1.48963190 |
| 171 | Nephropathy (HP:0000112) | 1.46380116 |
| 172 | Poor coordination (HP:0002370) | 1.43978092 |
| 173 | Aplasia of the musculature (HP:0100854) | 1.42406809 |
| 174 | Bifid scrotum (HP:0000048) | 1.39826937 |
| 175 | Abnormality of renin-angiotensin system (HP:0000847) | 1.39777004 |
| 176 | Preaxial hand polydactyly (HP:0001177) | 1.38822040 |
| 177 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.32179859 |
| 178 | Bell-shaped thorax (HP:0001591) | 1.32169137 |
| 179 | Lip pit (HP:0100267) | 1.27585383 |
| 180 | Polydipsia (HP:0001959) | 1.27225153 |
| 181 | Abnormal drinking behavior (HP:0030082) | 1.27225153 |
| 182 | Abnormality of the frontal sinuses (HP:0002687) | 1.22574372 |
| 183 | Abnormality of dentin (HP:0010299) | 1.20581903 |
| 184 | Stage 5 chronic kidney disease (HP:0003774) | 1.20069532 |
| 185 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.17720440 |
| 186 | Asplenia (HP:0001746) | 1.17253111 |
| 187 | Short thorax (HP:0010306) | 1.16181011 |
| 188 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.13912329 |
| 189 | Congenital sensorineural hearing impairment (HP:0008527) | 1.11962341 |
| 190 | Retinitis pigmentosa (HP:0000510) | 1.11938239 |
| 191 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.11084154 |
| 192 | Abnormality of macular pigmentation (HP:0008002) | 1.10860242 |
| 193 | Narrow forehead (HP:0000341) | 1.10051261 |
| 194 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.08475823 |
| 195 | Supernumerary spleens (HP:0009799) | 1.05036324 |
| 196 | Abnormality of the renal cortex (HP:0011035) | 1.03603970 |
| 197 | Glucose intolerance (HP:0000833) | 1.01938777 |
| 198 | Adrenal overactivity (HP:0002717) | 1.00929704 |
| 199 | Abnormality of abdominal situs (HP:0011620) | 0.99538771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.13404365 |
| 2 | MST4 | 6.01818308 |
| 3 | SIK1 | 4.59561631 |
| 4 | FGFR4 | 4.43606075 |
| 5 | ERN1 | 4.16629541 |
| 6 | STK24 | 3.63801817 |
| 7 | INSRR | 3.02138022 |
| 8 | TAOK3 | 2.92239660 |
| 9 | ERBB4 | 2.82365963 |
| 10 | MAPKAPK3 | 2.31007989 |
| 11 | MST1R | 2.30069842 |
| 12 | PKN2 | 2.23738216 |
| 13 | CCNB1 | 2.23127374 |
| 14 | MAP2K4 | 2.18901593 |
| 15 | PTK2B | 2.01355195 |
| 16 | FLT3 | 1.92101602 |
| 17 | MAPK11 | 1.79703544 |
| 18 | LATS1 | 1.73490887 |
| 19 | TRIB3 | 1.71653092 |
| 20 | PIK3CG | 1.69742561 |
| 21 | STK39 | 1.67297914 |
| 22 | TYK2 | 1.66104703 |
| 23 | FRK | 1.61366647 |
| 24 | DAPK2 | 1.58800433 |
| 25 | NEK9 | 1.50827405 |
| 26 | STK16 | 1.48733183 |
| 27 | FGFR2 | 1.44347146 |
| 28 | PTK6 | 1.44067241 |
| 29 | ABL2 | 1.43700108 |
| 30 | TTK | 1.34155423 |
| 31 | LRRK2 | 1.27155198 |
| 32 | KDR | 1.23741190 |
| 33 | OXSR1 | 1.21030029 |
| 34 | STK10 | 1.20664040 |
| 35 | NME1 | 1.20129114 |
| 36 | PINK1 | 1.18575715 |
| 37 | JAK2 | 1.18283590 |
| 38 | PRKAA2 | 1.17318229 |
| 39 | MAP3K7 | 1.17146376 |
| 40 | TRPM7 | 1.16125402 |
| 41 | BCR | 1.14238480 |
| 42 | MAP2K3 | 1.14061021 |
| 43 | MAP3K3 | 1.10064567 |
| 44 | MUSK | 1.07602506 |
| 45 | MAP3K12 | 1.07038484 |
| 46 | TLK1 | 1.05984301 |
| 47 | STK38L | 1.05607556 |
| 48 | PNCK | 1.04808265 |
| 49 | TIE1 | 1.04099743 |
| 50 | TESK1 | 1.00930540 |
| 51 | JAK1 | 1.00884377 |
| 52 | MAP3K14 | 0.99903376 |
| 53 | TBK1 | 0.99496242 |
| 54 | GRK6 | 0.99156045 |
| 55 | ERBB2 | 0.97950838 |
| 56 | ERBB3 | 0.96987360 |
| 57 | EEF2K | 0.96974253 |
| 58 | MAPK15 | 0.95441722 |
| 59 | MAPK4 | 0.94228367 |
| 60 | PRKCI | 0.92280944 |
| 61 | ACVR1B | 0.91160010 |
| 62 | CAMK1D | 0.90209561 |
| 63 | MET | 0.89852005 |
| 64 | PRKCZ | 0.89474680 |
| 65 | WEE1 | 0.88910084 |
| 66 | STK3 | 0.88180125 |
| 67 | LMTK2 | 0.85775350 |
| 68 | CDK12 | 0.85520470 |
| 69 | CDK6 | 0.85464450 |
| 70 | MYLK | 0.84459098 |
| 71 | NEK6 | 0.83719436 |
| 72 | BMPR1B | 0.83569386 |
| 73 | PDK2 | 0.82786035 |
| 74 | EPHB1 | 0.82095754 |
| 75 | TGFBR2 | 0.80645235 |
| 76 | WNK4 | 0.77263447 |
| 77 | IRAK3 | 0.77235012 |
| 78 | RIPK1 | 0.76786225 |
| 79 | MAPK12 | 0.76287961 |
| 80 | EPHA3 | 0.75668414 |
| 81 | MAP3K10 | 0.75484038 |
| 82 | CSK | 0.75357971 |
| 83 | PRKACG | 0.73760456 |
| 84 | MAP3K11 | 0.73724974 |
| 85 | PHKG2 | 0.71715187 |
| 86 | PHKG1 | 0.71715187 |
| 87 | GSK3A | 0.70946757 |
| 88 | AKT2 | 0.70473463 |
| 89 | EIF2AK1 | 0.70014237 |
| 90 | SGK3 | 0.69755252 |
| 91 | MAP2K6 | 0.69451098 |
| 92 | CAMK2G | 0.68265433 |
| 93 | FER | 0.67055143 |
| 94 | DYRK1B | 0.66542694 |
| 95 | PRKAA1 | 0.64951413 |
| 96 | BRSK2 | 0.62172891 |
| 97 | FGFR3 | 0.61770802 |
| 98 | GRK1 | 0.60867664 |
| 99 | MAP3K4 | 0.58395639 |
| 100 | PTK2 | 0.58065875 |
| 101 | MAPK7 | 0.57230363 |
| 102 | AURKA | 0.55435169 |
| 103 | TRIM28 | 0.55116103 |
| 104 | IKBKE | 0.55073479 |
| 105 | AKT3 | 0.52543281 |
| 106 | PDPK1 | 0.52464748 |
| 107 | SGK2 | 0.52424686 |
| 108 | TAOK2 | 0.51722485 |
| 109 | CSF1R | 0.51709022 |
| 110 | PRKCE | 0.50128486 |
| 111 | MAP2K1 | 0.49240299 |
| 112 | PRKCQ | 0.48409636 |
| 113 | IGF1R | 0.47997779 |
| 114 | DMPK | 0.47692091 |
| 115 | CSNK1G1 | 0.47614371 |
| 116 | ADRBK1 | 0.45467074 |
| 117 | TAOK1 | 0.44467490 |
| 118 | ROCK2 | 0.44356832 |
| 119 | PBK | 0.44277030 |
| 120 | EIF2AK3 | 0.43972200 |
| 121 | PRKACA | 0.43085148 |
| 122 | NTRK3 | 0.42863648 |
| 123 | PDK3 | 0.42229163 |
| 124 | PDK4 | 0.42229163 |
| 125 | ILK | 0.41883838 |
| 126 | MAP3K5 | 0.41743070 |
| 127 | STK38 | 0.41545055 |
| 128 | TGFBR1 | 0.39677050 |
| 129 | SMG1 | 0.39647475 |
| 130 | WNK3 | 0.39514816 |
| 131 | SGK223 | 0.38974241 |
| 132 | SGK494 | 0.38974241 |
| 133 | PRKCD | 0.37894463 |
| 134 | CAMK1G | 0.35331505 |
| 135 | RET | 0.35183822 |
| 136 | CDK4 | 0.34390522 |
| 137 | EGFR | 0.34289462 |
| 138 | PRKCG | 0.32853332 |
| 139 | MTOR | 0.32573296 |
| 140 | EPHA4 | 0.32324268 |
| 141 | MAP3K6 | 0.31584707 |
| 142 | MAP2K2 | 0.30559184 |
| 143 | ADRBK2 | 0.30335638 |
| 144 | CHUK | 0.30105784 |
| 145 | CAMK4 | 0.29919935 |
| 146 | NLK | 0.29750051 |
| 147 | SGK1 | 0.29414494 |
| 148 | PDK1 | 0.28958522 |
| 149 | PKN1 | 0.28735761 |
| 150 | MAP3K13 | 0.27483100 |
| 151 | CSNK1G2 | 0.26715771 |
| 152 | PRKCA | 0.26050068 |
| 153 | PLK2 | 0.25712059 |
| 154 | PIK3CA | 0.25266381 |
| 155 | ABL1 | 0.25203128 |
| 156 | PAK3 | 0.25101486 |
| 157 | ICK | 0.24931106 |
| 158 | EPHA2 | 0.24785207 |
| 159 | MAP3K2 | 0.24739466 |
| 160 | IRAK1 | 0.24283641 |
| 161 | DYRK1A | 0.23600352 |
| 162 | CSNK1G3 | 0.23461712 |
| 163 | BMPR2 | 0.22037830 |
| 164 | CAMK2A | 0.20893744 |
| 165 | MELK | 0.20344211 |
| 166 | RPS6KA5 | 0.20286847 |
| 167 | MARK3 | 0.19991704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.45092294 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.52185491 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.44326552 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.29663905 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.00885807 |
| 6 | Huntingtons disease_Homo sapiens_hsa05016 | 2.94693786 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70358342 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.68404459 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68367477 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.58828397 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49978834 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49462661 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.40106328 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.34982844 |
| 15 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.19350102 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14110691 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.08502202 |
| 18 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.98870266 |
| 19 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.98478059 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.97713420 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.97413726 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92463148 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87234300 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81697416 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.81398951 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.79521875 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78705022 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75778836 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.70508301 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70006190 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66556704 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.60458696 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59596428 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56047350 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51280718 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49573348 |
| 37 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.47452232 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.47223321 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46945269 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.41598466 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38378684 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33244751 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30926810 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30454338 |
| 45 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.26780345 |
| 46 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.24538852 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22476760 |
| 48 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.21185742 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19439796 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.18212690 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17879890 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14126196 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12847153 |
| 54 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.08708289 |
| 55 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.07155928 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06223382 |
| 57 | Circadian rhythm_Homo sapiens_hsa04710 | 1.05316332 |
| 58 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.02430634 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01597160 |
| 60 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.99952303 |
| 61 | Tight junction_Homo sapiens_hsa04530 | 0.99232862 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98070564 |
| 63 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97369381 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95906070 |
| 65 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95773786 |
| 66 | Parkinsons disease_Homo sapiens_hsa05012 | 0.93619880 |
| 67 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93378185 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.92833010 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.91900868 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87173637 |
| 71 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85764316 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83352628 |
| 73 | Lysine degradation_Homo sapiens_hsa00310 | 0.79800170 |
| 74 | Alzheimers disease_Homo sapiens_hsa05010 | 0.79441320 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.74819595 |
| 76 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73786469 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73107408 |
| 78 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.72782438 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70313697 |
| 80 | Salivary secretion_Homo sapiens_hsa04970 | 0.67177297 |
| 81 | * Glutathione metabolism_Homo sapiens_hsa00480 | 0.63482514 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60280637 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59086971 |
| 84 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.55031829 |
| 85 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.53444508 |
| 86 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49326446 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46089430 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39176028 |
| 89 | Phototransduction_Homo sapiens_hsa04744 | 0.37732223 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.36473222 |
| 91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34630416 |
| 92 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.34205491 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.32818125 |
| 94 | Protein export_Homo sapiens_hsa03060 | 0.31306581 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25730930 |
| 96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.25709318 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25164112 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24645835 |
| 99 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.23890712 |
| 100 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22299100 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.21927453 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21521256 |
| 103 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.21392775 |
| 104 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18540346 |
| 105 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.18413894 |
| 106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.17041013 |
| 107 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.16494928 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14938210 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08125008 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01906828 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2439397 |
| 112 | Pertussis_Homo sapiens_hsa05133 | -0.2435716 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2399272 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2355496 |
| 115 | Amoebiasis_Homo sapiens_hsa05146 | -0.2352973 |
| 116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2266827 |
| 117 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2014549 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1928047 |
| 119 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1757470 |
| 120 | Hepatitis C_Homo sapiens_hsa05160 | -0.1706621 |
| 121 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1683892 |
| 122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1656232 |
| 123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1469773 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1388716 |
| 125 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1385211 |
| 126 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1282516 |
| 127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1121044 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1038412 |
| 129 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0664550 |
| 130 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0638618 |
| 131 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0454591 |

